SLC6A15 and allergic disease: A potential functional role of SLC6A15 in the atopic march is suggested by a recent study demonstrating selective inhibition of B(0)AT2 by the histamine H1 receptor antagonist loratadine40, which is clinically used for the treatment of allergic disease.